FIELD: medicine.
SUBSTANCE: invention is referred to the area of medicine and can be used for treatment of herpes hepatitis in children. The antiviral drugs prescribed included acyclovir (zovirax), valtrex, Isoprinosine, immunomodulatory drugs viferon, licopid, amixin, as well as ursodeoxycholic acid drugs, phosphogliv and viferon. Three different treatment protocols are used depending on the age. Doses, regimen and duration of exposure are established by protocols.
EFFECT: decreased terms of treatment; prevented development of complications; method can be used in out-patient setting.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHILDREN WITH MANIFESTATION OF LINGERING JAUNDICE IN NEONATAL PERIOD | 2009 |
|
RU2432938C2 |
METHOD OF TREATING CONGENITAL HEPATITIS C IN CHILDREN OF FIRST YEAR OF LIFE | 2009 |
|
RU2424794C1 |
METHOD OF TREATING CONGENITAL HEPATITIS B IN CHILDREN OF FIRST YEAR OF LIFE | 2011 |
|
RU2478397C2 |
METHOD OF TREATING PARVOVIRAL INFECTION B19 IN INFANTS | 2012 |
|
RU2487708C1 |
METHOD OF TREATING EPSTEIN-BARR VIRAL INFECTION IN HIV-INFECTED CHILDREN | 2014 |
|
RU2555474C1 |
METHOD FOR NON-SPECIFIC PREVENTION OF ACUTE RESPIRATORY INFECTIONS IN INFANTS WITH CHRONIC HERPETIC INFECTIONS - CYTOMEGALOVIRUS, EPSTEIN-BARR VIRUS | 2020 |
|
RU2750522C1 |
METHOD FOR TREATMENT OF VIRAL ENCEPHALITIS IN CHILDREN | 2022 |
|
RU2786753C1 |
METHOD OF TREATING GENERALIZED CYTOMEGALOVIRUS INFECTION IN CHILDREN OF EARLY AGE | 2015 |
|
RU2602953C1 |
METHOD FOR PATHOGENETIC CORRECTION OF METABOLIC DISORDERS IN INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS | 2020 |
|
RU2726070C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
Authors
Dates
2012-02-10—Published
2009-12-30—Filed